Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.

about

Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.

Item

http://www.wikidata.org/entity/Q47253498

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@en

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@nl

type

Item

label

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@en

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@nl

prefLabel

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@en

Effect of 3 Commercially Avail ...... : A Randomized Clinical Trial.

@nl

P1476

Effect of 3 Commercially Avail ...... s: A Randomized Clinical Trial

@en

P2093

Michael O Larson

http://www.w3.org/2001/XMLSchema#string

P Daniel Ward

http://www.w3.org/2001/XMLSchema#string

Richard B Cannon

http://www.w3.org/2001/XMLSchema#string

Samuel Braden

http://www.w3.org/2001/XMLSchema#string

P2860

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice

Validation of the Synkinesis Assessment Questionnaire

The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines.

Comparing individual means in the analysis of variance.

Understanding the minimum clinically important difference: a review of concepts and methods.

Multimodality approach to management of the paralyzed face.

Safety and efficacy of botulinum toxin type A following long-term use.

Management of synkinesis.

P304

141-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAFACIAL.2017.1393

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J Thomas

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28973094

http://www.w3.org/2001/XMLSchema#string

P932

5885958

http://www.w3.org/2001/XMLSchema#string